Solventum Inc. (SOLV) - Market Cap to Earnings

Solventum Inc. - graphic logo of issuer SOLV

Solventum Corporation is implementing advanced polymer solutions and digital diagnostics in dentistry and wound care. The current P/E valuation level in the GURU.Markets terminal produces a chart where the value 98.20 reflects the current business valuation. Strict FDA certifications and lobbying ensure stability, while sustainable development is based on the eco-friendly disposal of laboratory waste.

Solventum Health - SOLV Price to Earnings Ratio (period 03/01/2025 - 11/14/2026)

Analytical breakdowns for Solventum Corporation

- stock value and consensus price forecast:
- market capitalization indicators:
Comprehensive company analysis:Solventum Inc.
Manufactured product of Solventum

The P/E ratio reflects the market value of a single unit of net profit, indicating the investment payback period assuming constant income. Investors utilize this multiple to determine whether an asset is overbought or undervalued relative to its fundamental value. By analyzing the P/E of Solventum Corporation (SOLV), one can assess how effectively the company's network of sterile consumable manufacturing plants generates profit. The indicator's trend confirms the resilience of the business operating model amidst stringent product quality requirements.

Competing companies

Market Cap to Earnings hcahealthcare.com HCA|Price to Earnings Ratio Tenet Healthcare (THC)|Fresenius Medical Care - Price to Earnings Multiple|Encompass Health Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio UHS (uhsinc.com)|DaVita Inc - P/E Multiple|RadNet Inc - Market Price to Net Income Ratio|optioncarehealth.com (OPCH) - Price to Earnings Ratio|SGRY - Business Payback Period|Price to Earnings Ratio Premier, Inc.|EYE (National Vision Holdings) - Market Price to Net Income Ratio|Price to Earnings Ratio Progyny Corp (PGNY)|Ardent Health Partners - Price to Earnings Multiple|P/E Multiple SEM (Select Medical Inc.)|Company Value to Net Income ASTH|MD - Price to Earnings Ratio|Company Value to Net Income USPH (U.S. Physical Therapy, Inc.)|PNTG: P/E Multiple|Market Cap to Earnings Organogenesis (ORGO)|NUTX (Nutex Health Corp) - P/E Multiple|P/E Multiple Auna Health|P/E Multiple SBC|Business Payback Period evolus.com|Community Health Systems, Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio SKIN (beautyhealth.com)|MDWD: Price to Earnings Ratio|Market Cap to Net Income BTMD|JYNT: P/E Multiple|Price to Earnings Multiple DCGO|PIII (P3 Health Partners Inc.) - P/E Multiple|Market Cap to Earnings Gain Therapeutics, Inc. GANX|Price to Earnings Ratio EUDA (EUDA Health Holdings)|Price to Earnings Ratio BMGL (Basel Medical Group Limited)|CollPlant Biotechnologies Ltd. - Price to Earnings Ratio|CUPR: Price to Earnings Multiple|CCM: Price to Earnings Ratio|Company Value to Net Income AMS (American Shared Hospital Services)|MRM: P/E Multiple|Market Cap to Earnings Avalon GloboCare Corp (ALBT)|Price to Earnings Ratio DIH Holding|XAGE: Company Value to Net Income|P/E Multiple NIVF|P/E Multiple ATI Physical Therapy Inc. (ATIP)|P/E Multiple CMAX (caremax.com)|Market Price to Net Income Ratio KDLY (Kindly Health)|MODV - Price to Earnings Ratio|Market Cap to Earnings novointegrated.com|SunLink Health Systems (SSY) - Price to Earnings Ratio|Price to Earnings Ratio IMAC Holdings Inc